{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:38:19Z","timestamp":1792139899262,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1988,12,1]],"date-time":"1988-12-01T00:00:00Z","timestamp":596937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[1988,12]]},"DOI":"10.1007\/bf00914317","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T21:28:18Z","timestamp":1104614898000},"page":"549-561","source":"Crossref","is-referenced-by-count":133,"title":["Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid"],"prefix":"10.1007","volume":"12","author":[{"given":"B. S.","family":"Vishwanath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. C.","family":"Franson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0006-3002(63)90792-3","volume":"70","author":"L. L. M. Deenen Van","year":"1963","unstructured":"Van Deenen, L. L. M., andG. H. de Haas. 1963. The substrate specificity of phospholipase A.Biochim. Biophys. Acta 70:538?553.","journal-title":"Biochim. Biophys. Acta"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0005-2760(65)90041-X","volume":"106","author":"H. Bosch Van Den","year":"1965","unstructured":"Van Den Bosch, H., andL. L. M. Van Deenen. 1965. Chemical structure and biochemical significance of lysolecithins from rat liver.Biochim. Biophys. Acta 106:326?337.","journal-title":"Biochim. Biophys. Acta"},{"key":"CR3","first-page":"349","volume-title":"Liposomes from Physical Structure to Therapeutic Applications","author":"R. C. Franson","year":"1981","unstructured":"Franson, R. C. 1981. Intracellular metabolism of ingested phospholipids.In Liposomes from Physical Structure to Therapeutic Applications. G. Knight, editor. Elsevier-North Holland, New York. 349?380."},{"key":"CR4","first-page":"257","volume-title":"The phospholipase A of lysosomes.In Lysosomes in Biology and Pathology, Vol. 5","author":"M. Waite","year":"1976","unstructured":"Waite, M., H. Griffin, andR. C. Franson. 1976. The phospholipase A of lysosomes.In Lysosomes in Biology and Pathology, Vol. 5. A. Neuberger and E. L. Tatus, editors. Elsevier-North Holland, New York. 257?305."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/0024-3205(80)90181-2","volume":"26","author":"P. Vadas","year":"1980","unstructured":"Vadas, P., andJ. B. Hay. 1980. The release of phospholipase A2 from aggregated platelets and stimulated macrophages of sheep.Life Sci. 26:1721?1729.","journal-title":"Life Sci."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0005-2760(81)90272-1","volume":"655","author":"J. R. Traynor","year":"1981","unstructured":"Traynor, J. R., andK. S. Authi. 1981. Phospholipase A2 activity of lysosomal origin secreted by polymorphonuclear leucocytes during phagocytosis or on treatment with calcium.Biochim. Biophys. Acta 655:571?577.","journal-title":"Biochim. Biophys. Acta"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1042\/bj2000441","volume":"200","author":"P. D. Wightman","year":"1981","unstructured":"Wightman, P. D., M. E. Dahlgren, P. Davies, andR. J. Bonney. 1981. The selective release of phospholipase A2 by resident mouse peritoneal macrophages.Biochem. J. 200:441?444.","journal-title":"Biochem. J."},{"key":"CR8","first-page":"285","volume":"107","author":"P. Vadas","year":"1982","unstructured":"Vadas, P., andJ. B. Hay. 1982. The appearance and significance of phospholipase A2 in lymph draining tuberculin reactions.Am. J. Pathol. 107:285?291.","journal-title":"Am. J. Pathol."},{"key":"CR9","first-page":"90","volume":"113","author":"C. Lanni","year":"1983","unstructured":"Lanni, C., andE. L. Becker. 1983. Release of phospholipase A2 activity from rabbit peritoneal neutrophils by f-Met-Leu-Phe.Am. J. Pathol. 113:90?94.","journal-title":"Am. J. Pathol."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jb\/101.3.625","volume":"101","author":"K. Horigome","year":"1987","unstructured":"Horigome, K., M. Hayakawa, K. Inoue, andS. Nojima. 1987. Selective release of phospholipase A2 and lysophosphatidylserine-specific lysophospholipase from rat platelet.J. Biochem. 101:53?61.","journal-title":"J. Biochem."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3109\/00365528009181510","volume":"15","author":"T. J. Nevalainen","year":"1980","unstructured":"Nevalainen, T. J. 1980. The role of phospholipase A in acute pancreatitis.Scand. J. Gastroenterol. 15:641?650.","journal-title":"Scand. J. Gastroenterol."},{"key":"CR12","first-page":"873","volume":"104","author":"P. Vadas","year":"1984","unstructured":"Vadas, P. 1984. Plasma phospholipase A2 levels correlate with the hemodynamic and pulmonary changes in gram negative septic shock in man.J. Lab. Clin. Med. 104:873?881.","journal-title":"J. Lab. Clin. Med."},{"key":"CR13","first-page":"211","volume":"12","author":"W. Pruzanski","year":"1985","unstructured":"Pruzanski, W., P. Vadas, E. Stefanski, andM. B. Urowitz. 1985. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme.J. Rheumatol. 12:211?216.","journal-title":"J. Rheumatol."},{"key":"CR14","first-page":"51","volume":"7","author":"P. Vadas","year":"1984","unstructured":"Vadas, P., andW. Pruzanski. 1984. Role of extracellular phospholipase A2 in inflammation.Adv. Inflam. Res. 7:51?59.","journal-title":"Adv. Inflam. Res."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1016\/S0021-9258(19)83790-0","volume":"257","author":"F. H. Chilton","year":"1982","unstructured":"Chilton, F. H., J. T. O'Flaherty, C. E. Walsh, M. J. Thomas, R. L. Wykle, L. R. Dechatelet, andB. M. Waite. 1982. Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyI-2-O-acetyl-sn-glycero-3-phosphocholine.J. Biol. Chem. 257:5402?5407.","journal-title":"J. Biol. Chem."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/1523-1747.ep12285639","volume":"86","author":"W. Pruzanski","year":"1986","unstructured":"Pruzanski, W., P. Vadas, andV. Fornasier. 1986. Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits.J. Invest. Dermatol. 86:380?383.","journal-title":"J. Invest. Dermatol."},{"key":"CR17","first-page":"854","volume":"46","author":"L. A. Marshall","year":"1987","unstructured":"Marshall, L. A., E. Blazek, andJ. Chang. 1987. Characterization of an in vivo model for evaluation of phospholipase A2 inhibitors.Fed. Proc. 46:854.","journal-title":"Fed. Proc."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0041-0101(87)90286-8","volume":"25","author":"B. S. Vishwanath","year":"1987","unstructured":"Vishwanath, B. S., R. M. Kini, andT. V. Gowda. 1987. Characterization of three edemainducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid.Toxicon 25:501?515.","journal-title":"Toxicon"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0041-0101(87)90155-3","volume":"25","author":"B. S. Vishwanath","year":"1987","unstructured":"Vishwanath, B. S., andT. V. Gowda. 1987. Interaction of aristolochic acid withVipera russelli phospholipase A2: Its effect on enzymatic and pathological activities.Toxicon 25:929?937.","journal-title":"Toxicon"},{"key":"CR20","first-page":"40","volume":"34","author":"L. H. Tsai","year":"1980","unstructured":"Tsai, L. H., L. L. Yang, andC. Chang. 1980. Inactivation of Formosan snake venoms in vivo by aristolochic acid, the chemical component ofAristolochia radix.Tai-wan K'o Hsueh. 34:40?44.","journal-title":"Tai-wan K'o Hsueh."},{"key":"CR21","first-page":"1560","volume":"45","author":"A. A. Fawzy","year":"1986","unstructured":"Fawzy, A. A., R. Dobrow, andR. C. Franson. 1986. Modulation of human synovial phospholipase A2 by monovalent cations.Fed. Proc. 45:1560.","journal-title":"Fed. Proc."},{"key":"CR22","first-page":"1945","volume":"46","author":"R. Raghupathi","year":"1987","unstructured":"Raghupathi, R., andR. C. Franson. 1987. Isolation of a Ca2+-dependent phospholipase A2 from human platelets.Fed. Proc. 46:1945.","journal-title":"Fed. Proc."},{"key":"CR23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0022-2275(20)36786-9","volume":"15","author":"R. Franson","year":"1974","unstructured":"Franson, R., P. Patriarca, andP. Elsbach. 1974. Phospholipid metabolism by phagocytic cells. Phospholipase A2 associated with rabbit polymorphonuclear leukocyte granules.J. Lipid Res. 15:380?388.","journal-title":"J. Lipid Res."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4684-0886-7_10","volume-title":"Animal Plant and Microbial Toxins, Vol. 1","author":"M. Yamakawa","year":"1976","unstructured":"Yamakawa, M., M. Nozaki, andZ. Hokama. 1976. Fractionation of Sakishima-habu (Trimeresurus elegans) venom and lethal hemorrhagic and edema forming activity of the fractions.In Animal Plant and Microbial Toxins, Vol. 1. A. Ohsaka, K. Hayashi, and Y. Sawai, editors. Plenum, New York. 97?109."},{"key":"CR25","first-page":"650A","volume":"31","author":"R. C. Franson","year":"1983","unstructured":"Franson, R. C., andD. Weir. 1983. Inhibition of a potent phospholipase A2 activity by nonsteroidal antiinflammatory agents in synovial fluid from patients with rheumatoid arthritis.Clin. Res. 31:650A.","journal-title":"Clin. Res."},{"key":"CR26","first-page":"17","volume-title":"Advances in Inflammation Research, vol. 3","author":"R. C. Robinson","year":"1982","unstructured":"Robinson, R. C., D. P. Curran, andP. J. Hamer. 1982. Prostaglandins and related compounds in inflammatory rheumatic disease.In Advances in Inflammation Research, vol. 3. M. Ziff, G. P. Velo, and S. Gorini, editors. Raven Press, New York, 17?27."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.77.5.2533","volume":"77","author":"F. Hirata","year":"1980","unstructured":"Hirata, F., E. Schiffmann, K. Venkatasubramanian, D. Salomon, andJ. Axelrod. 1980. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids.Proc. Natl. Acad. Sci. U.S.A. 77:2533?2536.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/287147a0","volume":"287","author":"G. J. Blackwell","year":"1980","unstructured":"Blackwell, G. J., R. Carnuccio, M. Dirosa, R. J. Flower, L. Parente, andP. Persico. 1980. Macrocortin: A polypeptide causing the anti-phospholipase effect of glucocorticoids.Nature 287:147?149.","journal-title":"Nature"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1476-5381.1983.tb10526.x","volume":"79","author":"J. F. Cloix","year":"1983","unstructured":"Cloix, J. F., O. Colard, B. Rothhut, andF. Russo-Marie. 1983. Characterization and partial purification of ?renocortins?: Two polypeptides formed in renal cells causing the anti-phospholipase like action of glucocorticoids.Br. J. Pharmacol. 79:313?321.","journal-title":"Br. J. Pharmacol."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0021-9258(19)75694-4","volume":"262","author":"F. F. Davidson","year":"1987","unstructured":"Davidson, F. F., E. A. Dennis, M. Powell, andJ. R. Glenney. 1987. Inhibition of phospholipase A2 by ?lipocortins? and calpactins. An effect of binding to substrate phospholipids.J. Biol. Chem. 262:1698?1705.","journal-title":"J. Biol. Chem."},{"key":"CR31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0005-2760(79)90117-6","volume":"575","author":"R. Jesse","year":"1979","unstructured":"Jesse, R., andR. Franson. 1979. Modulation of purified phospholipase A2 activity from human platelets by calcium and indomethacin.Biochim. Biophys. Acta 575:467?470.","journal-title":"Biochim. Biophys. Acta"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/bj1860633","volume":"865","author":"R. Franson","year":"1980","unstructured":"Franson, R., D. Eisen, R. Jesse, andC. Lanni. 1980. Inhibition of highly purified mammalian phospholipase A2 by nonsteroidal anti-inflammatory agents: Modulation by calcium ions.Biochem. J. 865:633?636.","journal-title":"Biochem. J."},{"key":"CR33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0041-0101(81)90108-2","volume":"19","author":"E. Condrea","year":"1981","unstructured":"Condrea, E., J. E. Fletcher, B. E. Rapuano, C.-C. Yang, andP. Rosenberg. 1981. Dissociation of enzymatic activity from lethality and pharmacological properties by carbamylation of lysines inNaja nigricollis, andNaja naja atra snake venom phospholipase A2.Toxicon 19:705?720.","journal-title":"Toxicon"},{"key":"CR34","first-page":"131","volume-title":"Natural Toxins","author":"M. C. Boffa","year":"1981","unstructured":"Boffa, M. C., C. Rothen, H. M. Verheij, R. Verger, andG. H. de Haas. 1981. Classification of phospholipase A2 based upon their anticoagulant activity and penetration ability into phospholipid monolayers.In Natural Toxins. D. Eaker, and T. Wadstrom, editors. Pergamon Press, Oxford. 131?138."},{"key":"CR35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.1711040103","volume":"104","author":"M. Rosa Di","year":"1971","unstructured":"Di Rosa, M., J. P. Giroud, andD. A. Willoughby. 1971. Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine.J. Pathol. 104:15?29.","journal-title":"J. Pathol."},{"key":"CR36","first-page":"286","volume":"Suppl. 4","author":"H. Bekemeier","year":"1979","unstructured":"Bekemeier, H., A. J. Giessler, R. Hirschelmann, andG. Metzner. 1979. Relationship between prostaglandins and lysophosphatides in the inflammatory process.Agents Actions (Suppl. 4): 286?292.","journal-title":"Agents Actions"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0304-4157(79)90004-2","volume":"559","author":"H. U. Weltzien","year":"1979","unstructured":"Weltzien, H. U., 1979. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine.Biochim. Biophys. Acta 559:259?287.","journal-title":"Biochim. Biophys. Acta"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0041-0101(87)90156-5","volume":"25","author":"B. S. Vishwanath","year":"1987","unstructured":"Vishwanath, B. S., A. G. A. Rao, andT. V. Gowda. 1987. Interaction of phospholipase A2 fromVipera russelli venom with aristolochic acid: A circular dichroism study.Toxicon 25:939?946.","journal-title":"Toxicon"},{"key":"CR39","first-page":"3","volume-title":"Principles of Rheumatic Diseases","author":"M. Yaron","year":"1982","unstructured":"Yaron, M. 1982. Structure and function of connective tissue joints, and synovial fluid.In Principles of Rheumatic Diseases. R. S. Panush, editor. John Wiley & Sons, New York. 3?14."},{"key":"CR40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0005-2760(84)90302-3","volume":"794","author":"E. M. Kyger","year":"1984","unstructured":"Kyger, E. M., andR. C. Franson. 1984. Non-specific inhibition of enzymes byp-bromophenacyl bromide. Inhibition of human platelet phospholipase C and modification of sulfhydryl groups.Biochim. Biophys. Acta 794:96?103.","journal-title":"Biochim. Biophys. Acta"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1021\/bi00704a020","volume":"13","author":"J. J. Volwerk","year":"1974","unstructured":"Volwerk, J. J., W. A. Pieterson, andG. H. De Haas. 1974. Histidine at the active site of phospholipase A2.Biochemistry 13:1446?1454.","journal-title":"Biochemistry"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0041-0101(81)90118-5","volume":"19","author":"E. Condrea","year":"1981","unstructured":"Condrea, E., J. E. Fletcher, B. E. Rapuano, C.-C. Yang, andP. Rosenberg. 1981. Effect of modification of one histidine residue on the enzymatic and pharmacological properties of a toxic phospholipase A2 fromNaja nigricollis snake venom and less toxic phospholipase A2 fromHematchatus haemachatus andNaja naja atra snake venoms.Toxicon 19:61?71.","journal-title":"Toxicon"},{"key":"CR43","first-page":"307","volume-title":"The Enzymes, Vol. 16","author":"E. A. Dennis","year":"1983","unstructured":"Dennis, E. A., 1983. Phospholipases.In The Enzymes, Vol. 16. P. D. Boyer, editor. Academic Press, New York. 307?353."},{"key":"CR44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0041-0101(86)90173-X","volume":"24","author":"R. M. Kini","year":"1986","unstructured":"Kini, R. M., andS. Iwanaga. 1986. Structure-function relationships of phospholipases I: Prediction of presynaptic neurotoxicity.Toxicon 24:527?541.","journal-title":"Toxicon"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0041-0101(86)90090-5","volume":"24","author":"R. M. Kini","year":"1986","unstructured":"Kini, R. M., andS. Iwanaga. 1986. Structure-function relationships of phospholipases II: Charge density distribution and the myotoxicity of presynaptically neurotoxic phospholipases.Toxicon 24:895?905.","journal-title":"Toxicon"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1016\/0006-2952(83)90298-8","volume":"32","author":"P. Rosenberg","year":"1983","unstructured":"Rosenberg, P., E. Condrea, B. Rapuano, K. Soons, andC.-C. Yang. 1983. Dissociation of pharmacological and enzymatic activities of snake venom phospholipase A2 by modification of carboxylate groups.Biochem. Pharmacol. 32:3525?3530.","journal-title":"Biochem. Pharmacol."},{"key":"CR47","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0041-0101(84)90157-0","volume":"22","author":"P. L. Barrington","year":"1984","unstructured":"Barrington, P. L., E. Condrea, K. R. Soons, C.-C. Yang, andP. Rosenberg. 1984. Effect of carboxylate group modification on enzymatic and cardiotoxic properties of snake venom phospholipase A2.Toxicon 22:743?758.","journal-title":"Toxicon"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0041-0101(81)90046-5","volume":"19","author":"J. B. Harris","year":"1981","unstructured":"Harris, J. B., andC. A. MacDonell. 1981. Phospholipase A2 activity of notexin and its role in muscle damage.Toxicon 19:419?430.","journal-title":"Toxicon"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1432-1033.1980.tb04982.x","volume":"112","author":"H. M. Verheij","year":"1980","unstructured":"Verheij, H. M., M. C. Boffa, C. Rothen, M. C. Bryckaert, R. Verger, andG. H. De Haas. 1980. Correlation of enzymatic activity and antocoagulant properties of phospholipase A2.Eur. J. Biochem. 112:25?32.","journal-title":"Eur. J. Biochem."},{"key":"CR50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/15569548209019475","volume":"1","author":"H. Fraenkel-Conrat","year":"1983","unstructured":"Fraenkel-Conrat, H. 1983. Snake venom neurotoxins related to phospholipase A2.J. Toxicol-Toxin Rev. 1:205?221.","journal-title":"J. Toxicol-Toxin Rev."},{"key":"CR51","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0041-0101(84)90080-1","volume":"22","author":"H.-C. Huang","year":"1984","unstructured":"Huang, H.-C. 1984. Release of slow reacting substance from the guinea-pig lung by phospholipase A2 ofVipera russelli snake venom.Toxicon 22:359?372.","journal-title":"Toxicon"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1139\/y83-086","volume":"61","author":"P. Vadas","year":"1983","unstructured":"Vadas, P., andJ. B. Hay. 1983. Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxic shock.Can. J. Physiol. Pharmacol. 61:561?566.","journal-title":"Can. J. Physiol. Pharmacol."}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00914317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00914317\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00914317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T10:58:51Z","timestamp":1625309931000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00914317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,12]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1988,12]]}},"alternative-id":["BF00914317"],"URL":"https:\/\/doi.org\/10.1007\/bf00914317","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,12]]}}}